Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
44.43
+0.08 (0.18%)
At close: Nov 19, 2025, 4:00 PM EST
45.29
+0.86 (1.94%)
Pre-market: Nov 20, 2025, 8:50 AM EST
Qiagen Employees
Qiagen had 5,967 employees as of December 31, 2023. The number of employees decreased by 211 or -3.42% compared to the previous year.
Employees
5,967
Change (1Y)
-211
Growth (1Y)
-3.42%
Revenue / Employee
$347,039
Profits / Employee
$67,936
Market Cap
9.63B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5,967 | -211 | -3.42% |
| Dec 31, 2022 | 6,178 | 150 | 2.49% |
| Dec 31, 2021 | 6,028 | 418 | 7.45% |
| Dec 31, 2020 | 5,610 | 514 | 10.09% |
| Dec 31, 2019 | 5,096 | 144 | 2.91% |
| Dec 31, 2018 | 4,952 | 264 | 5.63% |
| Dec 31, 2017 | 4,688 | 4 | 0.09% |
| Dec 31, 2016 | 4,684 | 125 | 2.74% |
| Dec 31, 2015 | 4,559 | 220 | 5.07% |
| Dec 31, 2014 | 4,339 | 324 | 8.07% |
| Dec 31, 2013 | 4,015 | 16 | 0.40% |
| Dec 31, 2012 | 3,999 | 61 | 1.55% |
| Dec 31, 2011 | 3,938 | 351 | 9.79% |
| Dec 31, 2010 | 3,587 | 92 | 2.63% |
| Dec 31, 2009 | 3,495 | 454 | 14.93% |
| Dec 31, 2008 | 3,041 | 379 | 14.24% |
| Dec 31, 2007 | 2,662 | 708 | 36.23% |
| Dec 31, 2006 | 1,954 | 365 | 22.97% |
| Dec 31, 2005 | 1,589 | 267 | 20.20% |
| Dec 31, 2004 | 1,322 | -231 | -14.87% |
| Dec 31, 2003 | 1,553 | -98 | -5.94% |
| Dec 31, 2002 | 1,651 | 94 | 6.04% |
| Dec 31, 2001 | 1,557 | 242 | 18.40% |
| Dec 31, 2000 | 1,315 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
QGEN News
- 20 hours ago - Qiagen N.V. (QGEN) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 days ago - Qiagen N.V. (QGEN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript - Seeking Alpha
- 10 days ago - QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025 - Business Wire
- 13 days ago - Seattle's Parse Biosciences to be acquired by Qiagen for $225M - GeekWire
- 14 days ago - Qiagen N.V. (QGEN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase - Business Wire
- 15 days ago - QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions - Business Wire
- 22 days ago - QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing - Business Wire